SAMMAANCAP - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 2.4
| Stock Code | SAMMAANCAP | Market Cap | 20,176 Cr. | Current Price | 174 ₹ | High / Low | 193 ₹ |
| Book Value | 172 ₹ | Dividend Yield | 0.00 % | ROCE | 3.24 % | ROE | -5.14 % |
| Face Value | 2.00 ₹ | DMA 50 | 162 ₹ | DMA 200 | 151 ₹ | Chg in FII Hold | 21.3 % |
| Chg in DII Hold | -2.23 % | PAT Qtr | -1,956 Cr. | PAT Prev Qtr | 285 Cr. | RSI | 55.8 |
| MACD | 6.12 | Volume | 77,26,235 | Avg Vol 1Wk | 1,05,11,697 | Low price | 114 ₹ |
| High price | 193 ₹ | Debt to equity | 2.41 | 52w Index | 76.5 % | Qtr Profit Var | -766 % |
| EPS | -65.6 ₹ | Industry PE | 15.5 |
📊 Entry Zone: Attractive accumulation only near 140 ₹ – 155 ₹. Current price (174 ₹) is above fair value given weak fundamentals.
📈 Exit / Holding Strategy: For existing holders, adopt a cautious stance. Consider short-to-medium horizon (12–18 months) with staggered exits near 185–190 ₹. Weak ROE (-5.14%) and ROCE (3.24%) combined with negative EPS (-65.6 ₹) suggest limited long-term compounding potential. High debt-to-equity (2.41) adds risk.
Positive
✔️ Strong FII interest (+21.3% change in holdings).
✔️ Price momentum supported by RSI (55.8) and MACD (6.12).
✔️ Trading volume remains healthy, showing liquidity.
✔️ Book value (172 ₹) close to CMP, offering valuation support.
Limitation
⚠️ ROE (-5.14%) and ROCE (3.24%) reflect poor capital efficiency.
⚠️ EPS (-65.6 ₹) indicates negative earnings.
⚠️ Debt-to-equity ratio (2.41) highlights high leverage risk.
⚠️ PAT collapsed (-1,956 Cr. vs 285 Cr. previous quarter).
⚠️ No dividend yield, reducing attractiveness for income investors.
Company Negative News
❌ Severe quarterly loss (-1,956 Cr.) raises sustainability concerns.
❌ High leverage may strain balance sheet in downturns.
❌ DII holdings reduced (-2.23%), showing weaker domestic confidence.
Company Positive News
✅ Strong foreign institutional support (+21.3% FII).
✅ Technical strength with price above DMA 50 (162 ₹) and DMA 200 (151 ₹).
✅ 52-week index at 76.5% shows resilience despite earnings collapse.
Industry
🌐 Industry PE (15.5) much lower than company valuation, highlighting overpricing.
📉 Sector faces risks from rising debt and weak profitability.
📈 Long-term demand outlook remains steady, but company-specific risks dominate.
Conclusion
🔎 SAMMAANCAP is a weak candidate for long-term investment due to poor profitability, high leverage, and negative earnings. Strong FII support and technical momentum provide short-term opportunities, but fundamentals remain fragile. Best strategy: accumulate only near 140–155 ₹, hold short-to-medium term, and plan staggered exits near 185–190 ₹. Long-term compounding is not advisable until earnings stabilize.
Would you like me to extend this into a sector overlay comparison with peers, or refine it into a swing trading analysis using RSI/MACD overlays for short-term positioning?